rectal cancer

Research in Review

Older Patients With Advanced-Stage Rectal Cancer Often Receive Sub-Optimal Treatment

08/01/2017

JCP Editors

A majority of older patients with stage II or III rectal adenocarcinoma do not receive standard-of-care treatment, according to recent research published in Cancer (online July 31, 2017;...

A...

08/01/2017

Journal of Clinical Pathways

Research in Review

Surveillance More Effective Than Surgery for Patients With Rectal Cancer After First-Line Care

05/09/2017

JCP Editors

Patients with rectal cancer who undergo first-line chemotherapy and radiation have lower risk of recurrence and higher rates of survival regardless of whether they choose to have surgery, according to a study...

...

05/09/2017

Journal of Clinical Pathways

Research in Review

Radiotherapy Combined With Delayed Surgery Reduces Adverse Effects of Rectal Cancer Treatment

02/13/2017

JCP Editors

Short-course preoperative radiotherapy combined with delayed surgery reduces the adverse effects of rectal cancer surgery while maintaining its efficiency, according to a study published in The Lancet (published...

...

02/13/2017

Journal of Clinical Pathways

Research in Review

Surgery Plus Chemoradiotherapy Better for Patients With Rectal Cancer

10/25/2016

JCP Editors

Patients with stage II or stage III rectal cancer may have better outcomes when treated with surgery and chemoradiotherapy than those who receive chemoradiotherapy alone, according to an article published in JAMA...

...

10/25/2016

Journal of Clinical Pathways

Conference Coverage

2016 Genitourinary Cancers Symposium

01/28/2016

JCP Editors

The American Society of Clinical Oncology’s 2016 Genitourinary Cancers Symposium was held earlier this month (January 7-9) in San Francisco, California, where the brightest professionals in urology, oncology, and...

The...

01/28/2016

Journal of Clinical Pathways